SL Science Holding SLBT
NASDAQ SLBT
$1.24 +0.04 (+3.78%)
As of: Oct 28, 2026 · 1:19 PM EDT

SL Science Holding (SLBT) Debt Ratio (2025 - 2026)

Updated

SL Science Holding's (SLBT) Debt Ratio stood at 0.03 in Q1 2026, down 92.9% from the prior quarter.

Analysis

SL Science Holding (SLBT) Debt Ratio (2025 - 2026) Analysis & Trends

For FY2025, SL Science Holding's Debt Ratio came in at 0.35.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,151.15 Bn 1,119.74 Bn 19.71 Bn 0.39
2 Johnson & Johnson 653.13 Bn 573.00 Bn 17.30 Bn 0.23
3 AbbVie 508.68 Bn 481.80 Bn 12.70 Bn 0.52
4 Merck 346.47 Bn 300.84 Bn 12.21 Bn 0.42
5 Novartis Ag 302.60 Bn 275.84 Bn - -
6 Astrazeneca 264.03 Bn 237.72 Bn 12.86 Bn 0.28
7 Amgen 243.23 Bn 198.63 Bn 7.24 Bn 0.60
8 Gilead Sciences 198.57 Bn 172.77 Bn 6.22 Bn 0.53
9 Pfizer 167.07 Bn 113.71 Bn 10.94 Bn 0.31
10 SL Science Holding 2.69 Bn 2.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.03
Dec 31, 2025 0.35
API Access

SL Science Holding Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=SLBT&period=max&api_key=YOUR_API_KEY